Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study.

BMC Ophthalmol · 2019 · PMC6873695 · PMID 31752769

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significanceP = 0.058so close (0.05 < p ≤ 0.1)

A significantly greater number of PDT was needed in the deferred combination group than that in the initial combination group ( P = 0.025, 2-sample t -test). The mean total number of anti-VEGF therapy on eyes with subtype 1 PCV was greater than that on eyes with subtype 2 PCV with borderline significance (6.75 vs 4.23, P = 0.058, 2-sample t -test).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.